Strides Pharma Science is well on track to achieve the FY25 outlook of $275 million-$290 million, post-demerger.

IST, the barometer index, the S&P BSE Sensex, rallied 139 points or 0.18% to 76,671.96. The Nifty 50 index added 57.60 points or 0.25% to 23,220.70.

A day ahead of the results, Vedanta shares were in demand, as the scrip rose up to 1.62 per cent to hit an intraday high of ...

Results: Adani Ports and Special Economic Zone net profit for the October-December 2024 quarter increased 14% year on year to ...

Adani Ports now expects its full-year EBITDA to be between ₹18,800 crore to ₹18,900 crore from the earlier guidance of ...

SRF anticipates a stronger Q4, driven by improved demand across its specialty chemicals, fluorochemicals, and agrochemicals segments.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Indian carmaker Tata Motors fell more than 7% in early trade on Thursday after reporting a bigger-than-expected drop in ...

Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates, as ...

Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...

We recently compiled a list of the 15 Best Monthly Dividend Stocks To Buy Right Now. In this article, we are going to take a ...